Pharma & Biotech Global Week in Review 5 Jan 2011 from IP Think Tank

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.

Highlights this week included:

Takeda completes settlements with 11 generics, finally ending Actos patent dispute (Patent Docs)

Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored.

General

AUTM’s 2010 Better World Report highlights (PatentlyBIOtech)

Drug R&D advocate named Kenyan ambassador to UN Geneva (IP Watch)

US: Patent eligibility and In re Grams (Patent Docs)

US: Main Hastings files false marking complaint against Pfizer based on products from its animal health division (Patent Docs)

US: IDEXX files patent infringement complaint against Abbott Laboratories based on its sale of Architect HIV Ag/Ab Combo assay (Patent Docs)

US: Life Technologies files patent infringement suit against Biosearch over its sale of BHQplus fluorescent-labeled probes for DNA analysis (Patent Docs)

US: AUTM US licensing survey 2009 (PatentlyBIOtech)

US: More Members of Congress concerned about 510(k) reform (FDA Law Blog)

US: Top stories of 2010 #12 to #9 – Pay for delay; Biotech/Pharma industry recovery (Patent Docs)

US: Top stories of 2010 #8 to #5 – Written description requirement; en banc review of Therasense, CAFC affirms District Court in Wyeth PTA case (Patent Docs)

Products

Actos (Pioglitazone) – US: Takeda completes settlements with 11 generics, finally ending Actos patent dispute (Patent Docs)

Crestor (Rosuvastatin) – US: AstraZeneca denied asserting method patents in Crestor litigation (Patent Docs)

Erbitux (Cetuximab) – UK/EU: Andrew Brown, Duncan Curley reflect on Erbitux SPC decision (The SPC Blog)

Lipitor (Atorvastatin) – US: Pfizer files patent infringement suit against Dr Reddy’s in response to ANDA filing (Patent Docs)

Lovenox (Enoxaprin) – US: Amphastar renews generic Lovenox case against FDA (FDA Law Blog)

Lunesta (Eszopiclone) – US: Lupin settles Lunesta patent litigation with Sunovion (Patent Docs)

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: